We had access to complementary information for each patient, such as: sex; age; date of onset of symptoms; date of the medical consultation; initial patient classification; information about the patients' occupation; affiliation to the health system; travels (international or domestic); comorbidities; symptoms; and if they had had contact with a confirmed or suspected COVID-19 case. We collected 2,068 samples from April 18th to July 15th 2020.
-
Smart Pooling has a higher efficiency gain compared to two-step pooling and individual testing at every prevalence.
-
At a 20% prevalence, with 25,000 testing kits: